Overview

Effect of Omega-3 Fatty Acid on Neurobehavioral Status of Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Trial

Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
0
Participant gender:
All
Summary
This study is conducted to assess whether Omega-3 fatty acid improves neurobehavioral staus of children with Autism Spectrum Disorder and whether there is any correlation of this improvement with reference range of Omega-3 fatty acid.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Criteria
Inclusion Criteria:

Fulfills diagnosis of ASD by meeting DSM-5 diagnostic criteria. Written parental consent
for participation. Age of children: 2-18 years. Sex: all.

-

Exclusion Criteria:

Those taking Omega-3 fatty acid or fish oil at present. Known allergy to fish or fish oil.
Diagnosed with a psychotic disorder (e.g. Schizophrenia) or mood disorder, including
depression or bipolar disorder.